Category: September 2026

  • Unpaid specialist training strains SA doctors

    Unpaid specialist training is becoming an increasingly visible feature of South Africa’s public health system as doctors compete for a limited number of funded training posts. Some local doctors are working without salaries for extended periods to gain the clinical experience required to qualify as specialists. Almost all of the clinical training required for specialisation and sub-specialisation takes place in…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Discovery earnings growth strengthens

    Discovery earnings growth strengthened in its latest financial year as investments in banking, health and international operations increasingly translated into profit and cash generation. The group reported a 17% increase in normalised operating profit to R17.75 billion. Cash conversion reached 85%, while the full-year dividend increased 33% to 384 cents per share. Discovery’s share price has also reflected growing investor…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Childhood vaccination rates under review

    Childhood vaccination rates published by the Department of Health may overstate the decline in immunisation coverage because of uncertainty about South Africa’s population estimates. The department recently warned of an immunisation crisis, saying more than a third of infants under one had received no vaccinations. However, it has since acknowledged that population figures supplied by Statistics South Africa (Stats SA)…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Maternal Mortality: SA Off Track for 2030 Target

    South Africa is not cutting maternal mortality fast enough to reach its 2030 goal, with the rate falling only about 1.5% a year, a specialist has warned. Dr Olivia Barigye, a foetal and maternal medicine specialist, said the latest confidential enquiry into maternal deaths shows the decline stalling, and even reversing slightly. She was speaking at the recent Women’s Health…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Preventable Maternal Deaths Are a Failure of Equity

    South Africa has a sophisticated economy, advanced medical training and a constitution that guarantees reproductive health care. Yet its maternal mortality ratio is rising, and most of these are preventable maternal deaths. The country recorded 111.7 maternal deaths per 100,000 live births in 2023, up from 109.6 in 2022 and 98.8 in 2019, before Covid-19. Foetal maternal medicine specialist Dr…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • FHC Targets Sterile Injectables Market After Activo Health Buy

    Portuguese pharmaceutical group FHC will use its acquisition of Activo Health to build its African footprint, beginning with a push into South Africa’s sterile injectables market, senior executives said yesterday. The privately held group bought Activo Health from JSE-listed Afrocentric. FHC owns Laboratórios Basi, a drugmaker based in Mortágua, Portugal, which reported turnover of about €543m (roughly R10bn) in 2025.…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Local Lenacapavir Production: Aspen Exits, Eyes Alimatravir

    Aspen is giving up on local lenacapavir production because demand isn’t guaranteed. Instead, the company is supporting Merck’s alimatravir pill as a means of preventing HIV. Aspen Pharmacare has walked away from government plans to produce lenacapavir locally. This is the clearest sign yet that South Africa’s bid to make its own HIV prevention injection faces stiff commercial headwinds. Instead,…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Discovery Group Results: Profit Climbs 17% to R17.75bn

    Discovery Group results for the year to 30 June 2026 show normalised profit from operations up 17% to R17.75bn. This growth was driven by its South African businesses and the international Vitality operations. The group also lifted its final ordinary dividend 36% to 273 cents per share. Headline earnings rose 34% and normalised headline earnings 21%. Meanwhile, normalised return on…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Mandatory Medical Scheme Membership Could Lower Costs

    Making mandatory medical scheme membership a requirement for everyone earning above the tax threshold could cut cover costs by up to 30%. This is according to research commissioned by the Health Funders Association (HFA). The findings appear in a report released yesterday. The HFA, which represents medical schemes and administrators covering roughly half the market, modelled two linked reforms: compulsory…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Mediscor Medicines Review: Medicine Spend Rose 4.7% in 2025

    Medicine benefits remain one of the clearest ways members feel the value of their medical scheme, according to the 2025 Mediscor Medicines Review. The report describes not runaway growth but steady pressure from utilisation, high-cost therapies, chronic disease and member affordability. The analysis draws on fee-for-service schemes with ongoing Mediscor PBM contracts, covering more than 1 million beneficiaries. Year-on-year shifts,…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Aspen Pharmacare Earnings Jump 22% on Mounjaro Demand

    Aspen Pharmacare earnings surged in its latest financial year, with normalised headline earnings per share climbing 22% on the back of booming demand for weight-loss medicines. Africa’s largest drugmaker reported the rise on Wednesday for the year ending 30 June. The standout driver was Eli Lilly’s Mounjaro, which Aspen promotes and sells across South Africa and other Sub-Saharan African markets…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Traditional Health Practitioners Set for NHI Role

    According to Dr Joe Phaahla, Deputy Minister of Health, the government intends to include traditional health practitioners as it introduces National Health Insurance (NHI). He announced this during his speech at the African Traditional Medicine Commemorative Day in Mpumalanga. The commitment establishes a formal place for traditional medicine within South Africa’s universal health coverage schemes. It aligns the country with…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in